Literature DB >> 22362737

Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation.

Hideharu Hashimoto1, Yiwei Liu, Anup K Upadhyay, Yanqi Chang, Shelley B Howerton, Paula M Vertino, Xing Zhang, Xiaodong Cheng.   

Abstract

Cytosine residues in mammalian DNA occur in at least three forms, cytosine (C), 5-methylcytosine (M; 5mC) and 5-hydroxymethylcytosine (H; 5hmC). During semi-conservative DNA replication, hemi-methylated (M/C) and hemi-hydroxymethylated (H/C) CpG dinucleotides are transiently generated, where only the parental strand is modified and the daughter strand contains native cytosine. Here, we explore the role of DNA methyltransferases (DNMT) and ten eleven translocation (Tet) proteins in perpetuating these states after replication, and the molecular basis of their recognition by methyl-CpG-binding domain (MBD) proteins. Using recombinant proteins and modified double-stranded deoxyoligonucleotides, we show that DNMT1 prefers a hemi-methylated (M/C) substrate (by a factor of >60) over hemi-hydroxymethylated (H/C) and unmodified (C/C) sites, whereas both DNMT3A and DNMT3B have approximately equal activity on all three substrates (C/C, M/C and H/C). Binding of MBD proteins to methylated DNA inhibited Tet1 activity, suggesting that MBD binding may also play a role in regulating the levels of 5hmC. All five MBD proteins generally have reduced binding affinity for 5hmC relative to 5mC in the fully modified context (H/M versus M/M), though their relative abilities to distinguish the two varied considerably. We further show that the deamination product of 5hmC could be excised by thymine DNA glycosylase and MBD4 glycosylases regardless of context.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362737      PMCID: PMC3367191          DOI: 10.1093/nar/gks155

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

5-hydroxymethylcytosine (5hmC) is a constituent of nuclear DNA, present in many tissues and cell types (1), but relatively enriched in embryonic stem cells (2) and Purkinje neurons (3). 5hmC in the mammalian genome depends on pre-existing 5-methylcytosine (5mC) (4). There are three mammalian ten eleven translocation (Tet) proteins that convert 5mC to 5hmC (2). In non-CpG context (CpA or CpT), 5mC is asymmetrical and 5hmC occurs largely DNA strand-specific (4). In the context of the palindromic CpG dinucleotide, 5hmC presumably exists as fully hydroxymethylated (H/H) form in cells and persists through cell division (5,6). However, the question remains how these H/H sites are maintained after semi-conservative DNA replication. 5hmC has also been proposed as a potential intermediate in active DNA demethylation via the base excision repair pathway (7,8). Methyl-CpG-binding domain 4 (MBD4) contains both an N-terminal MBD and a C-terminal thymine glycosylase domain that acts on G:T and G:U mismatches (9). Of particular interest is a recent report indicating that, in zebrafish, the activation-induced cytidine deaminase (AID) and MBD4 cooperate to demethylate DNA (10). Consistent with a role in DNA demethylation in mammals, AID is required to demethylate pluripotency genes during reprogramming of the somatic genome in embryonic stem cell fusions (11), and AID-deficient animals are less efficient in erasure of DNA methylation in primordial germ cells (12). It is noteworthy that AID promotes 5mC deamination, resulting in thymine (10,13), as well as 5hmC deamination, which would produce 5-hydroxymethyluracil (5hmU or hU) (8). Here, using in vitro biochemical methods, we investigated whether hydroxymethylation is maintained after DNA replication, whether methyl-DNA binding proteins inhibit Tet1 activity, and whether the deamination product of hydroxymetylcytosine could be excised by the glycosylase activities of MBD4 and thymine DNA glycosylase (TDG).

MATERIALS AND METHODS

Protein expression and purification

The expression constructs used to generate recombinant proteins in this study are listed in Supplementary Table S1 and detailed purification schemes are provided in Supplementary Methods. All constructs (except hDNMT1 full length) were expressed in Escherichia coli BL21 (DE3) Codon-plus RIL (Stratagene) harboring the RIL-Codon plus plasmid. 6×His-SUMO-tagged and non-cleavable 6×His-tagged proteins were expressed using modified pET28b vectors pETHisSumo (14) or pET6H (15), respectively. Glutathione S-transferase- (GST-) tagged proteins were expressed in pGEX-2T (GE healthcare) or a modified pET21d with GST inserted between BamHI and EcoRI restriction sites. In general, cells were cultured in Luria–Bertani (LB) medium (supplemented with 1 mM MgCl2 and 1 mM ZnCl2, and either 50 mg ml−1 kanamycin or 100 mg ml−1 ampicillin) at 37°C until OD600 of ∼0.5–1.0 before shifting the temperature down to 14–24°C. After 2–3 h, 0.2–0.4 mM isopropyl β-d-thiogalactoside was supplied to induce protein expression and cells were cultured overnight (∼12–16 h). For MBD1, the induction time was 2 h. For UHRF1 (residues 124–628), expression cultures were grown overnight at 25°C in auto-induction medium (16). Cells were harvested and lysed as a 20% (v/v) suspension in 20 mM sodium phosphate, pH 7.4 (or 20 mM HEPESNaOH, pH 7.0), 300–500 mM NaCl, 5% (v/v) glycerol, 0.5 mM tris(2-carboxyethyl)phosphine (TCEP) and 2 mM phenylmethylsulfonyl fluoride by two passes through an ice-cold French pressure cell press or by sonication (6 min total, 1 s on for 3 s off) for DNMT3 proteins. The lysate was clarified by centrifugation at 50 000g (or twice at 38 000g) for 50–60 min and filtered with cellulose nitrate membrane (Whatman). The following chromatographic columns (all from GE Healthcare) were used for purification: nickel-charged HisTrap-HP, HiTrap-Q, HiTrap-SP, HiTrap-Heparin, Sephacryl-300 (16/60), Superdex-200 (16/60), Superdex-75 (16/60), GSTrap. The 6×His-SUMO tag was cleaved by Ulp1 protease at 25 U ml−1 in room temperature for 2 h, whereas GST tag was cleaved by thrombin during dialysis in 20 mM TrisHCl, pH 8.5, 150 mM NaCl, 5% glycerol and 0.5 mM TCEP for 6 h at 4°C or by PreScission protease (for GST-p66β).

Overexpression of human DNMT1 in Pichia pastoris

Human DNMT1 full-length (residues 1–1616) is overexpressed in P. pastoris using the Multicopy Pichia Expression pPIC3.5K (Invitrogen) modified to include a His-tag at the N-terminus of expressed proteins. An NdeI site was added so that the dnmt1 gene can be inserted into the vector. A 6L-scale fermentation resulted in ∼500 ml of the induced cell pellets, which were divided into 32 tubes. The amount of soluble full-length DNMT1 was estimated to be around 9 mg per 15 ml cell pellets. Pichia expressed His6-tagged DNMT1 was purified with Ni-column, HiTrap-SP and Sephacryl-300 in the buffer of 20 mM HEPESNaOH, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM dithiothreitol (DTT) and further purified from associated nucleic acid through Q column, eluting at ∼250 mM NaCl in the same buffer with 0.5 mM TCEP, instead of DTT.

Methyl transfer assays using oligonucleotides

Methyl transfer activity assays were performed in 50 mM TrisHCl pH 7.5, 1 mM ethylenediaminetetraacetic acid (EDTA) (for DNMT1) or in 50 mM TrisHCl pH 7.5, 2.5% glycerol and 0.5 mM TCEP (for DNMT3A2/DNMT3L and DNMT3B2/DNMT3L). The reaction mixture (20 µl total volume) contained 5.5 µM [methyl-3H] AdoMet (10.0 Ci/mmol; Perkin Elmer) and 1.0 µM oligonucleotides (see below), and enzymes (20 nM DNMT1 N-terminal deletions Δ600, Δ644 and Δ728, or 200 nM DNMT1 FL and Δ350 or 300 nM DNMT3a2/3L and DNMT3B2/3L). All enzymes were pre-incubated with AdoMet for 10 min at 37°C before the addition of DNA. The reaction times for DNMT1 were 0–15 min, and terminated by the addition of 1.5 mM unlabeled S-adenosyl-l-homocysteine (AdoHcy). The reactions for DNMT3A2/DNMT3L, DNMT3B2/DNMT3L and DNMT3A-C/DNMT3L-C complex were carried out at 37°C for 0–60 min, and terminated by the addition of 1% sodium dodecyl sulfate and 1 mg ml−1 of protease K and heated at 50°C for 15 min. The reaction mixtures were spotted on DE81 paper circles (Whatman), washed twice with 5 ml of cold 0.2 M NH4HCO3, twice with 5 ml of deionized water and once with 5 ml of ethanol. The dried circles were subjected to liquid-scintillation counting with Cytoscint scintillant. Each reaction was performed in duplicate. To convert from counts-per-minute (cpm) to transferred methyl group concentration, we generated a linear calibration curve using 200 nM of HhaI methyltransferase to completely methylate 125, 250, 500 and 1000 nM of a 12-mer single CpG hemi-methylated DNA. After background subtraction, the resulting cpm's were plotted against the DNA concentration.

DNA binding assay

Fluorescence polarization measurements were carried out at 25°C on a Synergy 4 Microplate Reader (BioTek). A 10 nM of 6-carboxy-fluorescein (FAM)-labeled double strand DNA [FAM-5′-CCATGXGCTGAC-3′/5′-GTCAGYGCATGG-3′ where X and Y are C, 5mC (M), 5hmC (H), T, U or 5hmU] was incubated for 10 min with increasing amounts of proteins in binding buffer (20 mM TrisHCl, pH 7.5, 150 mM NaCl, 5% glycerol and 0.5 mM TCEP). No change in fluorescence intensity was observed with the addition of protein. Curves were fit individually using GraphPad PRISM 5.0d software (GraphPad Software Inc.). Binding constants (KD) were calculated as [mP] = [maximum mP] × [C]/(KD + [C]) + [baseline mP], and saturated [mP] was calculated as saturation = ([mP] − [baseline mP])/([maximum mP]–[baseline mP]), where [mP] is milli-Polarization and [C] is protein concentration. Averaged KD and its standard error were reported.

DNA glycosylase activity assay

DNA glycosylase activity assay was performed similar to previously described except FAM labeled DNA oligonucleotides were used instead of radio-labeled DNAs (15). Purified MBD4 or TDG protein (0.5 µM) and 0.5 µM of double strand FAM labeled 32-mer annealed DNA (see below) were mixed in 20 µl nick buffer (10 mM TrisHCl, pH 8.0, 1 mM EDTA, 0.1% BSA) and incubated at 37°C for 1 h. Reactions were stopped by adding 2 µl of 1 N NaOH, and boiled for 10 min before 20 µl of loading buffer (98% formamide, 1 mM EDTA and 1 mg ml−1 of bromophenol blue and xylene cyanole) were added and boiled for another 10 min. Samples were immediately put into ice water to cool down and loaded on a 10 × 10 cm2 denaturing PAGE gel containing 15% acrylamide, 7 M urea and 24% formamide in 1 × TBE buffer. The gels were run at 200 V for 60 min. FAM-labeled single strand DNA was visualized by UV exposure. The following olignonucleotides were synthesized at the New England Biolabs: where X, Y = C, 5mC (M), 5hmC (H), U, T or 5hmU (hU). (FAM)-5′-TCGGATGTTGTGGGTCAG 3′-AGCCTACAACACCCAGTCG

RESULTS

DNMT3a and DNMT3b have comparable activities on C/C, M/C and H/C substrates

In mammals, DNA methyltransferases (DNMTs) include three members, in two families that are structurally and functionally distinct (17). The DNMT3A and DNMT3B (18,19), coupled with regulatory factor Dnmt3-Like (DNMT3L) protein (20,21), establish the initial methylation pattern de novo, while DNMT1 and its accessory protein UHRF1 (ubiquitin-like, containing PHD and RING finger domains 1) (22,23) maintain this pattern during chromosome replication. We first asked which Dnmts methylate the newly synthesized cytosine in the context of hemi-hydroxymethylated CpG site (H/C) (Figure 1). Using a 32-bp DNA oligonucleotide containing a single CpG site, either unmodified (C/C), hemi-methylated (M/C) or hemi-hydroxymethylated (H/C), we find that whereas the known maintenance methyltransferase DNMT1 (24) has high intrinsic activity for the M/C substrate (Kcat = 6.6 h−1; Figure 1b and Supplementary Figure S1), it has measurable but greatly reduced activity for the H/C substrate (Kcat ∼ 0.1 h−1) and no detectable activity on C/C (Figure 1b). Thus, unlike M/C, H/C is not a preferred substrate of DNMT1 and is unlikely to be methylated by DNMT1 after replication, in agreement with previous findings (25). Consistent with this notion, UHRF1, which is essential for DNMT1 function and selectivity for hemi-methylated CpG (M/C) sites in vivo (22,23), loses its intrinsic preference for hemi-methylated DNA when 5mC is replaced by 5hmC. UHRF1 (residues 124–628) shows a >10-fold reduced binding affinity for H/C DNA as compared to M/C DNA, that was similar in magnitude to its affinity for fully methylated (M/M), fully hydroxymethylated (H/H) and H/M DNA (Figure 2a and Supplementary Discussion). Therefore, neither DNMT1 nor UHRF1 are likely to be involved in post-replicative maintenance of H/C methylation, which, without the involvement of DNMT3 (see below), would lead to ‘passive demethylation’ of 5hmC.
Figure 1.

DNMT3A and DNMT3B can methylate the cytosine in the context of hemi-hydroxylmethylated CpG site (H/C). (a) Diagram showing the potential fate of single CpG sites that are either unmodified (C/C), fully methylated (M/M) or fully hydroxymethylated (H/H) at DNA replication. After strand synthesis, unmodified (C/C), hemi-methylated (M/C) or hemi-hydroxymethylated (H/C) sites are transiently generated. MBD indicates DNA methyl-binding domain proteins, while Tet refers to ten–eleven translocation proteins. (b–d) Enzymatic activity of recombinant DNMT1, DNMT3A2/DNMT3L and DNMT3B2/DNMT3L against a 32-bp DNA containing a single unmodified (C/C), hemi-methylated (M/C) or hemi-hydroxymethylated (H/C) CpG site. Note that DNMT1 (panel b) has robust preference for maintenance methylation at M/C sites over H/C and C/C sites in naked oligonucleotide DNA, whereas DNMT3A2/3L (c) and DNMT3B2/3L (d) have approximately similar activities on all three substrates.

Figure 2.

Effect of hydroxymethylation on DNA methylation ‘readers’. Binding affinities of UHRF1 (residues 124–628) (a) and five MBD proteins (b–f) for a double stranded oligonucleotide containing a single CpG site with one of the six different modification states: unmodified (C/C), fully modified (M/M, H/H), hemi-(hydroxy)methylated (M/C, H/C) or hemi-methylated/hemi-hydroxymethylated (H/M) CpG site. Binding was assessed by fluorescence polarization. (a) UHRF1 has a strong preference for binding the hemi-methylated CpG (M/C) site. (b and c) MeCP2 and MBD1 have the strongest binding to fully methylated CpG (M/M). Although there is significantly lower affinity among the MBDs for H/M CpG dinucleotides (5-fold decreased affinity for MeCP2 and 18-fold for MBD1), this substrate is still preferred over hemi-methylated DNA (M/C), and is bound by MeCP2 and MBD1 with an affinity similar in magnitude to MBD2 (d), and greater affinity than MBD3 (e) and MBD4 (f) bind to fully methylated DNA (M/M). (g) Summary of relative binding affinities (by factor of x) of five MBD proteins for M/M and H/M substrates (top two lines). Note that the binding affinities of MeCP2 (and MBD1) for H/M and H/H are in the same order of magnitude as that of MBD2 and MBD4 to M/M substrate, respectively (lines 3 and 4).

DNMT3A and DNMT3B can methylate the cytosine in the context of hemi-hydroxylmethylated CpG site (H/C). (a) Diagram showing the potential fate of single CpG sites that are either unmodified (C/C), fully methylated (M/M) or fully hydroxymethylated (H/H) at DNA replication. After strand synthesis, unmodified (C/C), hemi-methylated (M/C) or hemi-hydroxymethylated (H/C) sites are transiently generated. MBD indicates DNA methyl-binding domain proteins, while Tet refers to ten–eleven translocation proteins. (b–d) Enzymatic activity of recombinant DNMT1, DNMT3A2/DNMT3L and DNMT3B2/DNMT3L against a 32-bp DNA containing a single unmodified (C/C), hemi-methylated (M/C) or hemi-hydroxymethylated (H/C) CpG site. Note that DNMT1 (panel b) has robust preference for maintenance methylation at M/C sites over H/C and C/C sites in naked oligonucleotide DNA, whereas DNMT3A2/3L (c) and DNMT3B2/3L (d) have approximately similar activities on all three substrates. Effect of hydroxymethylation on DNA methylation ‘readers’. Binding affinities of UHRF1 (residues 124–628) (a) and five MBD proteins (b–f) for a double stranded oligonucleotide containing a single CpG site with one of the six different modification states: unmodified (C/C), fully modified (M/M, H/H), hemi-(hydroxy)methylated (M/C, H/C) or hemi-methylated/hemi-hydroxymethylated (H/M) CpG site. Binding was assessed by fluorescence polarization. (a) UHRF1 has a strong preference for binding the hemi-methylated CpG (M/C) site. (b and c) MeCP2 and MBD1 have the strongest binding to fully methylated CpG (M/M). Although there is significantly lower affinity among the MBDs for H/M CpG dinucleotides (5-fold decreased affinity for MeCP2 and 18-fold for MBD1), this substrate is still preferred over hemi-methylated DNA (M/C), and is bound by MeCP2 and MBD1 with an affinity similar in magnitude to MBD2 (d), and greater affinity than MBD3 (e) and MBD4 (f) bind to fully methylated DNA (M/M). (g) Summary of relative binding affinities (by factor of x) of five MBD proteins for M/M and H/M substrates (top two lines). Note that the binding affinities of MeCP2 (and MBD1) for H/M and H/H are in the same order of magnitude as that of MBD2 and MBD4 to M/M substrate, respectively (lines 3 and 4). De novo DNMT3 family includes two active enzymes, DNMT3A and DNMT3B (18,19), and one regulatory factor, DNMT3L protein (20,21). DNMT3L enhances methylation by both DNMT3A and DNMT3B (26–30) via direct interaction with the catalytic domain of DNMT3A and DNMT3B and stabilizing their binding of AdoMet (31). We purified DNMT3A2 [a shorter isoform of DNMT3A (32)] in complex with DNMT3L as well as the complex between DNMT3BΔ218 (deletion of N-terminal 218 residues, termed 3B2, approximately equivalent to DNMT3A2 in size) and DNMT3L (Supplementary Figure S2). Unlike DNMT1, DNMT3A2/3L and DNMT3B2/3L have approximately equal activities on all three (M/C, H/C, C/C) substrates, with Kcat values of 0.2–0.4 and ∼0.2 h−1, respectively (Figure 1c and d), suggesting that DNMT3A and DNMT3B do not distinguish various modifications in the hemi-modified context. The very slow catalytic turnover of DNMT3A and DNMT3B is probably due to the product binding of methylated DNA, considering that almost all of the cellular complement of DNMT3A and DNMT3B, but not DNMT1, is strongly anchored to nucleosomes containing methylated DNA (33,34).

Recognition of 5hmC by known MBDs

Tet proteins use 5mC as substrate to generate 5hmC (2). The amount of 5hmC, which inversely correlates with the amount of 5mC in Purkinje cell DNA and in granule cell DNA (3), could potentially be regulated by the combined cellular activities of Tet1-3 enzymes, DNMTs (through the regulation of the levels of 5mC substrate) and the methyl-specific DNA binding proteins (by binding and potentially masking 5mC), such as MeCP2, which is found in high concentrations in the brain (35). It was recently found that 5hmC levels in mouse cerebellum are negatively correlated with MeCP2 gene dosage (36). Consistent with this idea, we found that MeCP2 binding to methylated DNA inhibits Tet1 activity in vitro (Supplementary Figure S3). To explore the effect of DNA hydroxylation on the function of MBD proteins, we measured the dissociation constants (KD) between five MBD proteins and double stranded oligonucleotides containing a single CpG dinucleotide with six different modification states (C/C, M/C, H/C, M/M, H/M and H/H as shown in Figure 1a) using fluorescence polarization analysis. MeCP2 (residues 77–205) binds fully methylated DNA (M/M) with a KD of 10 nM; changing a single methyl group to hydroxylmethyl on one strand (H/M) increased the KD to 46 nM (an ∼5-fold weaker binding) (Figure 2b). Full hydroxymethylation (H/H) weakened the binding by another factor of 5 with KD of 0.26 µM, a value similar to that of H/C (0.19 µM) and about half of C/C (0.5 µM) (Figure 2b), suggesting that the hydroxyl group of 5hmC disrupted the specific interaction between MeCP2 and 5mC, reducing the binding affinity to that of unmodified cytosine. In comparison, there was little apparent discrimination in the context of hemi-modification (0.19 µM for H/C versus 0.13 µM for M/C). A similar trend was observed for the MBD domain of MBD1 (Figure 2c) and MBD2 (Figure 2d): each methyl group hydroxylation from M/M to H/M to H/H results in weaker binding (by a factor of 18 and 11 for MBD1 and 10 and 5 for MBD2, respectively). These results are in general agreement with the finding that MBD domains have a lower affinity toward sequences containing 5hmC (37,38). Nevertheless, it is noteworthy that the ability of the different MBDs to discriminate between these substrates (M/M versus H/M) varies considerably (from 2- to 18-fold), with MBD3 and MBD4 showing little discrimination (Figure 2e and f) (summarized in Figure 2g). Furthermore, although MeCP2 and MBD1 have significantly lower affinity for hemi-methylated and hemi-hydroxymethylated CpG dinucleotides (H/M) relative to M/M DNA (5- and 18-fold decreased affinity, respectively), this substrate is still preferred over hemi-methylated DNA (M/C) by a factor of ∼3, and is bound by MeCP2 and MBD1 with an affinity similar to that which MBD2 binds fully methylated (M/M) DNA, and a greater affinity than MBD3 and MBD4, bind to fully methylated DNA (M/M) (summarized in Figure 2g). These data suggest that in vivo there may be additional factors (e.g. relative local concentration, tissue-specific expression) that determine whether, and to what degree, 5hmC DNA is bound by MBDs.

Excision of 5hmU by MBD4 and TDG

In the pathway shown in Figure 3a, Tet-mediated production of 5hmC becomes the substrate for AID, which converts 5hmC to 5hmU. We thus tested whether 5hmU can be excised by MBD4 and TDG glycosylase domains (15,39). We used the same 32-bp DNA duplexes containing a G:X mismatch within the CpG sequence context (where X = 5hmU, T or U) as the substrate. The X-containing strand was FAM labeled, and the excision of the mismatched base was monitored by denaturing gel electrophoresis following NaOH hydrolysis (Supplementary Figure S4). As expected, no glycosylase activity was observed on oligonucleotides bearing the ‘natural’ G:C and G:M base pairs, and there was efficient cleavage of substrates bearing G:T and G:U mismatches (Figure 3b and c). We extend these findings to show here that the TDG and MBD4 glycosylases are also inactive on G:H (which preserves Watson–Crick base-pair hydrogen bonds; see Figure 3a), but act on G:5hmU mismatched substrates, and further, that the modification status (methyl or hydroxymethyl) of the C in the opposite strand of neighboring G had no impact on the ability to remove G:T, G:U or G:5hmU mismatches (Figure 3b and c). Therefore, TDG and MBD4 are capable of acting on AID-generated 5hmU and completing the ‘demethylation’ of 5hmC.
Figure 3.

MBD4 and TDG are capable of excising 5-hydroxymethyluracil in the context of a double-stranded CpG dinucleotide. (a) A putative pathway of DNA demethylation involving DNA methylation by DNMTs, hydroxylation by Tet proteins, deamination by AID and glycosylation by MBD4 or TDG linked to base excision repair (BER). Double stranded 32-bp oligonucleotides bearing a single CpG dinucleotide and the indicated modification status (where M = 5mC and H = 5hmC) and labeled with FAM on the top strand were incubated with the glycosylase domain of MBD4 (b) or TDG (c) at 37°C for 1 h. The products of the reaction were separated on a denaturing polyacrylamide gel, and the FAM-labeled strand was excited by UV and photographed.

MBD4 and TDG are capable of excising 5-hydroxymethyluracil in the context of a double-stranded CpG dinucleotide. (a) A putative pathway of DNA demethylation involving DNA methylation by DNMTs, hydroxylation by Tet proteins, deamination by AID and glycosylation by MBD4 or TDG linked to base excision repair (BER). Double stranded 32-bp oligonucleotides bearing a single CpG dinucleotide and the indicated modification status (where M = 5mC and H = 5hmC) and labeled with FAM on the top strand were incubated with the glycosylase domain of MBD4 (b) or TDG (c) at 37°C for 1 h. The products of the reaction were separated on a denaturing polyacrylamide gel, and the FAM-labeled strand was excited by UV and photographed.

DISCUSSION

Taken together, we suggest that DNMT3A and DNMT3B are capable of acting on the hemi-hydroxymethylated (H/C) CpG sites generated during DNA replication, to yield hemi-hydroxylated and hemi-methylated (H/M) CpG sites. Recently, a maintenance methylation function has been proposed for DNMT3A and DNMT3B (40), which have been suggested to complete the methylation of sites missed by or resistant to DNMT1 activity during DNA replication (e.g. repetitive DNA). Assuming H/M sites are substrates for modification by Tet proteins (Supplementary Figure S5), there is the potential for regenerating a fully modified hydroxymethylated H/H site, recapitulating the parental DNA state after replication (Figure 1a). It is interesting to note that while Dnmt3a (but not Dnmt3b or Dnmt1) expressed in both paternal and maternal pronuclei of mouse zygotes, Tet3 (but not Tet1 or Tet2) expressed specifically in the male pronucleus (41). The expression patterns of Dnmt3a and Tet3 coincide with the loss of methylation and occurrence of 5hmC in the early mouse embryo (5,6). We also showed that five MBD proteins have markedly varied abilities to discriminate M/M versus H/M substrates. MeCP2 and MBD1 bind H/M with an affinity similar to that which MBD2 binds fully methylated (M/M) DNA (Figure 2). These data suggest that MBD proteins (particularly MeCP2 and MBD1) may play a role in regulating the levels of 5hmC in vivo, by inhibiting Tet activities through their binding to M/M and H/M substrates. In mammals, all three Tet proteins, Tet1, Tet2 and Tet3 catalyze similar reactions, converting 5mC to 5hmC (42). One important future question will be to determine biochemically whether Tet proteins, like DNMTs, divide the labor among the family members, with one (or more) establishing the initial hydroxymethylation pattern de novo (i.e. using M/M as the substrate), and other(s) maintaining this pattern during chromosome replication (using H/M as the substrate). Finally, we demonstrated that MBD4 and TDG glycosylase domains are both active on AID-generated 5hmU and are thus capable completing the ‘active demethylation’ of 5hmC. An important future question will be to determine whether the two have largely complementary but context-dependent functions in 5hmC turnover. It would also be interesting to know whether Tet1-3 proteins interact with AID complex [including the damage response factor Gadd45 (10)] and TDG or MBD4 by some means.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online: Supplementary Table 1, Supplementary Figures 1–5, Supplementary Methods, Supplementary Discussion and Supplementary References [43-67].

FUNDING

U.S. National Institutes of Health (GM049245-18 to X.C.) and NIH (grants CA077337 and CA132065 to P.M.V.). X.C. is a Georgia Research Alliance Eminent Scholar and P.M.V. is a Georgia Cancer Coalition Distinguished Cancer Scholar. The open access publication charge for this paper has been waived by Oxford University Press - NAR Editorial Board members are entitled to one free paper per year in recognition of their work on behalf of the journal. Conflict of interest statement. None declared.
  67 in total

1.  A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei.

Authors:  H Leonhardt; A W Page; H U Weier; T H Bestor
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases.

Authors:  M Okano; S Xie; E Li
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

Review 3.  Cancer biology and NuRD: a multifaceted chromatin remodelling complex.

Authors:  Anne Y Lai; Paul A Wade
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.

Authors:  L S Chuang; H I Ian; T W Koh; H H Ng; G Xu; B F Li
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Cytosine-specific type II DNA methyltransferases. A conserved enzyme core with variable target-recognizing domains.

Authors:  R Lauster; T A Trautner; M Noyer-Weidner
Journal:  J Mol Biol       Date:  1989-03-20       Impact factor: 5.469

6.  5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.

Authors:  Keith E Szulwach; Xuekun Li; Yujing Li; Chun-Xiao Song; Hao Wu; Qing Dai; Hasan Irier; Anup K Upadhyay; Marla Gearing; Allan I Levey; Aparna Vasanthakumar; Lucy A Godley; Qiang Chang; Xiaodong Cheng; Chuan He; Peng Jin
Journal:  Nat Neurosci       Date:  2011-10-30       Impact factor: 24.884

7.  The BAH (bromo-adjacent homology) domain: a link between DNA methylation, replication and transcriptional regulation.

Authors:  I Callebaut; J C Courvalin; J P Mornon
Journal:  FEBS Lett       Date:  1999-03-05       Impact factor: 4.124

8.  The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes.

Authors:  Tian-Peng Gu; Fan Guo; Hui Yang; Hai-Ping Wu; Gui-Fang Xu; Wei Liu; Zhi-Guo Xie; Linyu Shi; Xinyi He; Seung-gi Jin; Khursheed Iqbal; Yujiang Geno Shi; Zixin Deng; Piroska E Szabó; Gerd P Pfeifer; Jinsong Li; Guo-Liang Xu
Journal:  Nature       Date:  2011-09-04       Impact factor: 49.962

9.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

Authors:  E Li; T H Bestor; R Jaenisch
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

10.  Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L.

Authors:  Déborah Bourc'his; Timothy H Bestor
Journal:  Nature       Date:  2004-08-18       Impact factor: 49.962

View more
  211 in total

1.  Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome.

Authors:  Miao Yu; Gary C Hon; Keith E Szulwach; Chun-Xiao Song; Liang Zhang; Audrey Kim; Xuekun Li; Qing Dai; Yin Shen; Beomseok Park; Jung-Hyun Min; Peng Jin; Bing Ren; Chuan He
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

Review 2.  Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics.

Authors:  Tijs Louwies; Casey O Ligon; Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2018-11-04       Impact factor: 3.598

3.  CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.

Authors:  Hai Pan; Stephanie M Bilinovich; Parminder Kaur; Robert Riehn; Hong Wang; David C Williams
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

4.  Establishment of methylation patterns in ES cells.

Authors:  Ofra Sabag; Ayelet Zamir; Ilana Keshet; Merav Hecht; Guy Ludwig; Amalia Tabib; Joshua Moss; Howard Cedar
Journal:  Nat Struct Mol Biol       Date:  2013-12-15       Impact factor: 15.369

Review 5.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 6.  Detecting and interpreting DNA methylation marks.

Authors:  Ren Ren; John R Horton; Xing Zhang; Robert M Blumenthal; Xiaodong Cheng
Journal:  Curr Opin Struct Biol       Date:  2018-07-19       Impact factor: 6.809

Review 7.  The role of 5-hydroxymethylcytosine in human cancer.

Authors:  Gerd P Pfeifer; Wenying Xiong; Maria A Hahn; Seung-Gi Jin
Journal:  Cell Tissue Res       Date:  2014-05-10       Impact factor: 5.249

8.  RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation.

Authors:  Bo-Kuan Wu; Szu-Chieh Mei; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  5-Hydroxymethylcytosine: generation, fate, and genomic distribution.

Authors:  Li Shen; Yi Zhang
Journal:  Curr Opin Cell Biol       Date:  2013-03-13       Impact factor: 8.382

Review 10.  5-Hydroxymethylcytosine--the elusive epigenetic mark in mammalian DNA.

Authors:  Edita Kriukienė; Zita Liutkevičiūtė; Saulius Klimašauskas
Journal:  Chem Soc Rev       Date:  2012-07-27       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.